FindTrial
Sign In

Sorbitol

DRUG5 trials

Sponsors

University of Turku, Kuwait University, ViiV Healthcare, Istanbul Medipol University Hospital, ScandiBio Therapeutics AB

Conditions

Alzheimer DiseaseBacterial InfectionsDental CariesInfection, Human Immunodeficiency VirusInfectious DiseasesNon-alcoholic Fatty Liver Disease (NAFLD)Parkinson Disease

Phase 1

Effect of Xylitol on Oral Microbiota in Children
CompletedNCT01528969
Kuwait UniversityBacterial Infections
Start: 2012-03-31End: 2012-05-31Updated: 2015-08-10

Phase 2

Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients
CompletedNCT04044131
Istanbul Medipol University HospitalAlzheimer Disease, Parkinson Disease
Start: 2019-12-02End: 2021-04-20Updated: 2022-08-08
Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease
CompletedNCT04330326
ScandiBio Therapeutics ABNon-alcoholic Fatty Liver Disease (NAFLD)
Start: 2019-07-20End: 2022-05-06Updated: 2025-02-10

Phase 4

Bifidobacterium Lactis BB12 and Xylitol Delivered With a Novel Slow-release Pacifier
CompletedNCT00638677
University of TurkuDental Caries, Infectious Diseases
Start: 2004-06-30End: 2012-08-31Updated: 2013-01-08
A Phase IV, Open Label, 4-period Cross-over Study to Investigate a Drug Interaction Between Lamivudine and Sorbitol Oral Solutions in Healthy Volunteers
CompletedNCT02634073
ViiV HealthcareInfection, Human Immunodeficiency Virus
Start: 2016-01-01End: 2016-03-11Updated: 2017-05-15

Related Papers

Pharmacokinetic and pharmacodynamic assessment of oral nicotinamide in the NEAT clinical trial for early Alzheimer’s disease
Alzheimer s Research & Therapy2025-03-117 citations
Multi-omics characterization of improved cognitive functions in Parkinson’s disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial
Brain Communications2024-12-24
Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial
Translational Neurodegeneration2023-01-2669 citations
Effect of Sorbitol on the Pharmacokinetic Profile of Lamivudine Oral Solution in Adults: An Open‐Label, Randomized Study
Clinical Pharmacology & Therapeutics2017-11-1835 citations
Administration of Bifidobacterium animalis subsp. lactis BB-12 in early childhood: a post-trial effect on caries occurrence at four years of age.
2013-04-0544 citations